WO2026073145A1 - Transmission optimisée de données d'analyte dans des environnements multi-récepteurs - Google Patents
Transmission optimisée de données d'analyte dans des environnements multi-récepteursInfo
- Publication number
- WO2026073145A1 WO2026073145A1 PCT/US2025/048507 US2025048507W WO2026073145A1 WO 2026073145 A1 WO2026073145 A1 WO 2026073145A1 US 2025048507 W US2025048507 W US 2025048507W WO 2026073145 A1 WO2026073145 A1 WO 2026073145A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- data
- analyte
- cam system
- connection
- devices
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Business, Economics & Management (AREA)
- General Business, Economics & Management (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Primary Health Care (AREA)
- Public Health (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Abstract
Dans un mode de réalisation, un aspect général comprend un procédé d'optimisation de la transmission de données depuis un dispositif vers une cible distante. Le procédé consiste à recevoir des mesures d'analyte en provenance d'un système de surveillance continue d'analyte (CAM). Le procédé consiste également à déterminer un état en cours d'une connexion entre le dispositif et le système CAM. Le procédé consiste également à transmettre de façon conditionnelle des données relatives aux mesures d'analyte sur un réseau vers une cible distante en fonction de l'état en cours de la connexion.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202463701057P | 2024-09-30 | 2024-09-30 | |
| US63/701,057 | 2024-09-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2026073145A1 true WO2026073145A1 (fr) | 2026-04-02 |
Family
ID=97676999
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2025/048507 Pending WO2026073145A1 (fr) | 2024-09-30 | 2025-09-29 | Transmission optimisée de données d'analyte dans des environnements multi-récepteurs |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2026073145A1 (fr) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2016370177A1 (en) * | 2015-12-18 | 2018-02-22 | Dexcom, Inc. | Data backfilling for continuous glucose monitoring |
| EP3295343B1 (fr) * | 2015-05-12 | 2020-04-01 | Dexcom, Inc. | Architecture de système répartie pour contrôle de glucose en continu |
| WO2024091412A1 (fr) * | 2022-10-24 | 2024-05-02 | Abbott Diabetes Care Inc. | Facilitation d'une connexion persistante à des systèmes de surveillance d'analyte à distance |
-
2025
- 2025-09-29 WO PCT/US2025/048507 patent/WO2026073145A1/fr active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3295343B1 (fr) * | 2015-05-12 | 2020-04-01 | Dexcom, Inc. | Architecture de système répartie pour contrôle de glucose en continu |
| AU2016370177A1 (en) * | 2015-12-18 | 2018-02-22 | Dexcom, Inc. | Data backfilling for continuous glucose monitoring |
| WO2024091412A1 (fr) * | 2022-10-24 | 2024-05-02 | Abbott Diabetes Care Inc. | Facilitation d'une connexion persistante à des systèmes de surveillance d'analyte à distance |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12295698B2 (en) | Transcutaneous analyte sensors and monitors, calibration thereof, and associated methods | |
| US10470660B2 (en) | Transcutaneous analyte sensors and monitors, calibration thereof, and associated methods | |
| US20230263479A1 (en) | Sensing systems and methods for providing diabetes decision support using continuously monitored analyte data | |
| US20240188904A1 (en) | Continuous glucose monitoring system insight notifications | |
| US20240194341A1 (en) | Determining user-specific hyperparameters for decision support models | |
| US20250204869A1 (en) | Alert optimization in multi-receiver environments | |
| US20250212044A1 (en) | Device-to-device mitigation of disrupted communication with analyte sensors | |
| WO2026073145A1 (fr) | Transmission optimisée de données d'analyte dans des environnements multi-récepteurs | |
| US20240420820A1 (en) | Integrating health data from multiple wearable devices | |
| US20260020780A1 (en) | Rapid detection of hypoglycemia incidence using continuous glucose monitoring | |
| US20240212801A1 (en) | Dynamic presentation of cross-feature correlation insights for continuous analyte data | |
| US20250204862A1 (en) | Dynamically handling substance interference with analyte sensor systems | |
| WO2026073051A1 (fr) | Optimisation d'identification d'événement par réalisation de transformées de données d'analyte spécifiques de patient | |
| WO2026073090A1 (fr) | Adaptation dynamique d'une détermination de taux de variation d'analyte à un contexte actuel de patient | |
| US20240172999A1 (en) | Determining decision support outputs using user-specific analyte level criteria | |
| WO2026019913A1 (fr) | Amélioration d'une précision de prédictions de glucose pour des patients en facilitant la soumission de données contextuelles | |
| US20250169769A1 (en) | Compression event detection for continuous glucose monitors | |
| WO2026025001A1 (fr) | Système et méthodes de détection, d'analyse et de présentation d'événements métaboliques | |
| WO2026039134A1 (fr) | Système d'intelligence artificielle pour gérer des concentrations d'analyte |